Sharps Technology’s Sc Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.
Sharps Technology的Sc資產收購和2億美元的注射器銷售協議爲在美國開始生產可預填充的特種共聚物注射器鋪平了道路
Sharps Technology’s Sc Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.
Sharps Technology的Sc資產收購和2億美元的注射器銷售協議爲在美國開始生產可預填充的特種共聚物注射器鋪平了道路
譯文內容由第三人軟體翻譯。